Newsroom
August 25, 2020
In the war on cancer and other diseases including COVID-19, old drugs approved for other conditions are being studied for new purposes. It’s a strategy that will now be tested in Alzheimer’s disease with a drug called rapamycin. A $2 million grant will enable a clinical trial in which 40 individuals with mild cognitive impairment […]
August 25, 2020
In the war on cancer and other diseases including COVID-19, old drugs approved for other conditions are being studied for new purposes. It’s a strategy that will now be tested in Alzheimer’s disease with a drug called rapamycin. A $2 million grant will enable a double-blind, placebo-controlled clinical trial in which 40 individuals with mild […]
August 3, 2020
Amy Garrett, PhD, assistant professor of radiology and psychiatry and director of the neuroimaging core for the Department of Psychiatry, was interviewed as an outside expert to provide context in this story about a new study that suggests experiencing adversity early in life is likely to make children reach puberty more quickly, increase cellular aging […]
July 22, 2020
Genes and cardiovascular health each contribute in an additive way to a person’s risk of dementia, researchers including Sudha Seshadri, MD, and Claudia Satizabal, PhD, of UT Health San Antonio reported July 20 in the journal Neurology. Read the story.
July 22, 2020
Researchers at UT Health San Antonio have discovered a new class of proteins that protect synapses from being destroyed. The discovery, published July 13 in the journal Nature Neuroscience, has implications for Alzheimer’s disease and schizophrenia. Read the story.
July 21, 2020
Genes and cardiovascular health each contribute additionally to a person’s risk of dementia, according to new research, published in the journal Neurology. The study was done by U.S. researchers including Sudha Seshadri, MD, and Claudia Satizabal, PhD. The study was conducted in 1,211 participants in the Framingham Heart Study and involved collaborators from Boston University. […]